To obtain any study, publication, article, please contact the technical resposible through the telephone number: +55 11 4301-3714 or 4301-3715.
1. Molecular basis for action of bioactive glasses as bone graft substitute.
Välimäki VV, Aro HT. Scandinavian Journal of Surgery. 2006;95(2):95-102.
2. Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in augmentation of bone defect healing.
Virolainen P, Heikkilä J, Yli-Urpo A, Vuorio E, Aro HT. J Biomed Mater Res. 1997;35A(1):9-17.
3. Treatment of a recurrent aneurysmal bone cyst with bioactive glass in a child allows for good bone remodelling and growth.
Lindfors NC. Bone. 2009;45:398-400.
4. A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors.
Lindfors NC, Koski I, Heikkilä JT, Mattila K, Aho AJ. J Biomed Mater Res. 2010;94B(1):157-164.
5. Bioactive glass S53P4 and autograft bone in treatment of depressed tibial plateau fractures. A prospective randomized 11-year follow-up.
Pernaa K, Koski I, Mattila K, Gullichsen E, Heikkilä J, Aho AJ, Lindfors N. J Long-term Eff Med Impl. 2011;21(2):139-148.
8. Histomorphometric and molecular biologic comparison of bioactive glass and autogenous bone graft – 1997
9. Bioactive Glass Hydroxiapatite in Fronto-Orbital Defect Reconstruction – 2007
10. Comparison of antibacterial effect of three bioactive glasses – 2006
11. Bioactive glass S53P4 in frontal sinus obliteration – 2006
12. Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro – 2007
13. Interaction between S53P4 and the atropic rhinitis-associated Klebsiella ozaenae – 1999
14. Bioactive glass S53P4 in the filling of cavities in the mastoid cell area – 2010